Register
Login:
Share:
Email Facebook Twitter


London South East Natural Resources Briefing webcast: #Emmerson #Alba #Condor Gold #Gold analysis
Angus Energy in talks to buy 'transformational' gas asset in North England


Glaxosmithkline Share Chat (GSK)



Share Price: 1,571.20Bid: 1,570.20Ask: 1,570.60Change: 0.00 (0.00%)No Movement on Glaxosmithkline
Spread: 0.40Spread as %: 0.03%Open: 1,547.00High: 1,571.20Low: 1,543.40Yesterday’s Close: 1,571.20


Share Discussion for Glaxosmithkline


Thread View

Please login or register to post a message on Share Chat.

Posts per page:

skier1
Posts: 3,590
Opinion:No Opinion
Price:1,549.00
GSK
19 Dec '18
Doubt this will end well in the long-term. The CEO is breaking Glaxo up into 2 smaller companies, which will make them more vulnerable to overseas takeover.
 
chittybangbang
Posts: 2,158
Opinion:No Opinion
Price:1,556.60
good news
19 Dec '18
From GSK today. The market seems to like the JV idea
Time2Retire
Posts: 267
Opinion:No Opinion
Price:1,531.80
The light at the end of the tunnel
19 Dec '18
can we now see the roadmap to the end of the tunnel.

1. Invest in biotech as they have the future returns
http://www.lse.co.uk/ShareNews.asp?shareprice=GSK&code=cms8p13v&headline=Pharma_industry_returns_on_RD_investment_hit_9year_low

2. JV on commercial side then spin it off.
Buzle
Posts: 804
Opinion:No Opinion
Price:1,468.00
Chart looks awful
14 Dec '18
On this and many other stocks atm.
AllAtSea
Posts: 879
Opinion:No Opinion
Price:1,479.20
Shingrix demand
12 Dec '18
December 12th, 2018 – GlaxoSmithKline's (GSK) Shingrix vaccine shortage is expected to persist 'throughout 2019', reported Eric Sagonowsky with FiercePharma.

The unexpected demand for Shringrx during 2018 has overwhelmed the company's ability to keep inventories full, forcing it to take steps, such as implementing order limits to doctors and pharmacies.

“We need to get the vaccine supply expanded as fast as possible," GSK’s Luke Miels, global pharmaceuticals president, told analysts on the company's 3rd-quarter conference call on October 31, 2018.

https://www.precisionvaccinations.com/gsk-shingles-vaccine-shingrix-inventory-constraints-may-continue-through-2019
AllAtSea
Posts: 879
Opinion:No Opinion
Price:1,471.60
RE: Good/buy ratings
12 Dec '18
The UK link citywire.co.uk/funds-insider/news/the-expert-view-glaxosmithkline-wpp-and-ashtead/a1184352?re=60547&ea=222385&utm_source=BulkEmail_FundsInsider+DawnChorus&utm_medium=BulkEmail_FundsInsider+DawnChorus&utm_campaign=BulkEmail_FundsInsider+DawnChorus#i=2
AllAtSea
Posts: 879
Opinion:No Opinion
Price:1,489.80
RE: Big fall today!
11 Dec '18
Hmmm...

Weren't the Fool saying buy just before they tanked?

Are they hinting at sell now they have fallen out of bed?

On that basis..??
alto1
Posts: 673
Opinion:No Opinion
Price:1,437.40
RE director deals
8 Dec '18
does not seem that positive to me! 02. Nov 18 Buy Manvinder Banga Individual 31. Oct 18 31. Oct 18 471 £15.26 £7,188
02. Nov 18 Buy Vivienne Cox Individual 31. Oct 18 31. Oct 18 348 £15.26 £5,312
02. Nov 18 Buy Philip Hampton Individual 31. Oct 18 31. Oct 18 2,867 £15.26 £43,750
02. Nov 18 Buy Urs Rohner Individual 31. Oct 18 31. Oct 18 471 £15.26 £7,188
08. Aug 18 Sell Claire Thomas Individual 07. Aug 18 07. Aug 18 -40,000 £15.95 £-637,848
25. Jul 18 Buy Manvinder Banga Individual 25. Jul 18 25. Jul 18 462 £15.57 £7,188
25. Jul 18 Buy Vivienne Cox Individual 25. Jul 18 25. Jul 18 341 £15.57 £5,312
25. Jul 18 Buy Philip Hampton Individual 25. Jul 18 25. Jul 18 2,810 £15.57 £43,750
25. Jul 18 Buy Urs Rohner Individual 25. Jul 18 25. Jul 18 462 £15.57 £7,188
15. May 18 Sell Philip Thomson Individual 15. May 18 15. May 18 -65,000 £14.70 £-955,285
07. Feb 18 Buy Manvinder Banga Individual 07. Feb 18 07. Feb 18 2,250 £12.78 £28,750
20. Feb 18 Sell Patrick J. Vallance Individual 16. Feb 18 16. Feb 18 -73,783 £11.57 £-853,833
18. Dec 17 Sell Patrick J. Vallance Individual 18. Dec 17 18. Dec 17 -52,974 £13.10 £-693,754
07. Feb 18 Buy Philip Hampton Individual 07. Feb 18 07. Feb 18 3,423 £12.78 £43,750
20. Feb 18 Sell Claire Thomas Individual 16. Feb 18 16. Feb 18 -35,473 £11.57 £-410,501
07. Feb 18 Buy Vivienne Cox Individual 07. Feb 18 07. Feb 18 416 £12.78 £5,313
20. Feb 18 Sell Philip Thomson Individual 16. Feb 18 16. Feb 18 -20,524 £11.57 £-237,508
07. Feb 18 Buy Roy Anderson Individual 07. Feb 18 07. Feb 18 562 £12.78 £7,187
20. Feb 18 Sell Emma Walmsley Individual 16. Feb 18 16. Feb 18 -65,247 £11.57 ????? £-755,053
07. Feb 18 Buy Urs Rohner Individual 07. Feb 18 07. Feb 18 562 £12.78 £7,188
iknowverylittle
Posts: 461
Opinion:No Opinion
Price:1,452.80
RE: Big fall today!
7 Dec '18
Making a nice recovery today by the looks of it.
Pokerchips
Posts: 7,182
Opinion:No Opinion
Price:1,450.60
RE: Big fall today!
7 Dec '18
The 52 week mid price is 1442.6p ..currently sitting at 1443p ....I decided to jump in at 1430p to diversify a bit
.... no certainty with any share at the moment
Zaman2515
Posts: 84
Opinion:No Opinion
Price:1,439.00
RE: Big fall today!
6 Dec '18
Falling continue today!
Pokerchips
Posts: 7,182
Opinion:No Opinion
Price:1,469.60
RE: Big fall today!
5 Dec '18
yesterday was a bull trap, ..the bulls buying off the bottom only for the bears to sell into that rise today ...

Investors working out the value of expected future earnings based on :

" Adjusted EPS growth at CER for the period 2016-2020 to be at the bottom end of the mid to high single digit percentage CAGR range."

" GSK expects the acquisition of TESARO and associated R&D and commercial investments will impact Adjusted EPS for the first two years by mid to high single digit percentages, reducing thereafter with the acquisition expected to start to be accretive to Adjusted EPS by 2022."

... CAGR - Compound Annual Growth Rate...key word being "compound"

2017 - Adjusted earnings per share 111p with dividend 80p ...the company is struggling to grow ...so this aquisition is a purchase to invest over the next 2 years in the hope it will bring growth

So..I would guess some investors are leaving GSK and may not return for the moment
Zaman2515
Posts: 84
Opinion:No Opinion
Price:1,469.60
Big fall today!
5 Dec '18
Can anybody please tell me the reason for falling today. Yesterday I thought it was settled the dust and it was getting up but today it seems completely different!
Farmertally
Posts: 1,827
Opinion:No Opinion
Price:1,511.00
RE: steady today
4 Dec '18
Yes exetrchief, the price tag banded about was between 3.5 & 4.2 Billion, amuses me that a few dodgy financial hacks with online calculators reckon that Emma has been done - always let the female negotiate when you know what you will pay. Not meant as sexist, but always know where you stand.

Don't know about buying anymore though - I think my divi portfolio may pay better, albeit for a bit more risk, with a plus 12% payer at a good price? Cant see GSK putting on a 20% capital increase in the next year or so.

Rightly or wrongly, sold 25% of holding @ 1635 - so will place elsewhere. G/L
stockplay
Posts: 220
Opinion:No Opinion
Price:1,511.00
RE: steady today
4 Dec '18
Hi Dinoken, it seems the ''Change: -110.60 (-6.82%)'' that we can see above in our screens is wrong, it might refer to yesterday, not today.
GSK was indeed steady today, taken fron the London Stock Exchange official site:
Price (GBX) 1,511.00
Var % (+/-) +0.87% (Up +13.00)
High 1,522.20
Low 1,499.60
exetrchief
Posts: 420
Opinion:No Opinion
Price:1,512.20
RE: steady today
4 Dec '18
$5 1 billion is what GSK have agreed for the purchase of Tesaro.Said to be approx £ 4 billion,with the US $ coming under increased pressure, is it likely the purchase price could end up more like £.3.5 billion or less?
Dinoken
Posts: 758
Opinion:No Opinion
Price:1,514.60
RE: steady today
4 Dec '18
Since when has a 7% drop been steady ? Same bearing as yesterday on my chart ...
stockplay
Posts: 220
Opinion:No Opinion
Price:1,514.00
steady today
4 Dec '18
I expected further falls today but the sp holds positive despite being a bad day for the markets. Changed my mind and bought a few hundred shares back in case the SP holds these levels, then we can see a lot higher. GLA
bob6
Posts: 788
Opinion:No Opinion
Price:1,514.40
yesterday
4 Dec '18
oversold
buying a company that will improve there chances of beating cancer has got to be good for all of us, in fact the whole
world as it seems to be on the rise posabble down to what we eat and pollution
so good luck emma and your team from one share holder
Grayling
Posts: 1,730
Opinion:Hold
Price:1,514.20
Strategy
4 Dec '18
Not sure I get this overall. The Witty regime exits the oncology market by selling the lot to Novartis for $16bn back in 2014. Four years later the new CEO re-enters the fray by buying a company with a lead oncology product in direct competition with others (mainly AZN in the UK at least) and the market deems that they have overpaid for the new assets? I for one am slightly confused.
Divann
Posts: 514
Opinion:No Opinion
Price:1,506.80
RE: Interesting
4 Dec '18
From Delaware, odd corporate laws there, heaven sent for lawyers




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk









Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.